MedPath

:â??COMPARISON OF PROPOFOL REQUIREMENT DURING THREE PHASES OF LIVER TRANSPLANT SURGERYâ??

Not Applicable
Conditions
Health Condition 1: K74- Fibrosis and cirrhosis of liver
Registration Number
CTRI/2023/01/049206
Lead Sponsor
DR YATIN KALRA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Adult patients diagnosed with CLD posted for Liver Transplant Surgery

Exclusion Criteria

1. Patient denying consent

2. Known allergy to eggs or propofol

3. Requirement for pretransplant mechanical ventilation

4. Use of vasopressors prior to transplantation.

5. Any modification in anaesthesia treating protocol

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the mean target concentration of propofol required to maintain BIS between 40-60 during the three phases of Liver Transplant SurgeryTimepoint: At the end of Dissection Phase - time of portal vein clamping during surgery <br/ ><br> <br/ ><br>At the end of Anhepatic Phase - At the time of portal vein unclamping during surgery <br/ ><br> <br/ ><br>At the end of Neohepatic Phase - Time of last skin suture during closure of abdomen <br/ ><br> <br/ ><br>of the liver transplant surgery
Secondary Outcome Measures
NameTimeMethod
To compare the total requirement of propofol in each of the three phases of Liver Transplant Surgery in pts with MELD 15-20, 20-25, more than 25Timepoint: End of Dissection Phase - At the time of portal vein clamping during surgery <br/ ><br> <br/ ><br>End of Anhepatic Phase - Time of portal vein unclamping during surgery <br/ ><br> <br/ ><br>End of Neohepatic Phase - Time of last skin suture during closure of abdomen;To compare the overall total requirement of propofol in pts with MELD 15-20, 20-25, more than 25Timepoint: Time of last skin suture during closure of abdomen
© Copyright 2025. All Rights Reserved by MedPath